Microarray Licence to the Norwegian Microarray Consortium
News Sep 02, 2005
Oxford Gene Technology (OGT) has announced that it has granted a microarray licence to the Norwegian Microarray Consortium (NMC).
This licence allows the NMC to extend its microarray sales into European territories covered by the OGT Southern array patents.
Dr Mike Evans, Chief Executive of OGT, said, “We are happy to support the NMC by granting this licence and thus further the use of microarray technology”.
Professor Ola Myklebost, Head of the NMC and the FUGE National Microarray Platform, said, “The agreement with OGT means that the National Microarray Platform can now offer all of its array products, including those for academic use, to customers in the UK, France, Germany, Italy, Austria, Belgium, Sweden, Switzerland, Luxembourg and The Netherlands”.
Over 130 Glaucoma Gene Variants Could Help Predict BlindnessNews
An international study has identified 133 genetic variants that could help predict the risk of developing glaucoma, the world’s leading cause of incurable blindness. The findings are an advance in the fight to tackle the incurable, degenerative condition, which has virtually no symptoms in the early stages, and could lead to a genetic-based screening program.READ MORE
Yeast Study Performs Hundreds of Simultaneous CRISPR EditsNews
A new technique which can alter hundreds of different genes at once in baker's yeast could greatly speed up CRISPR-Cas9 editing and offer a way to perform high-throughput functional genomics.READ MORE
Cell Types Underlying Schizophrenia IdentifiedNews
Scientists at Karolinska Institutet in Sweden and University of North Carolina, USA, have identified the cell types underlying schizophrenia in a new study published in Nature Genetics. The findings offer a roadmap for the development of new therapies to target the condition.READ MORE